$PSNL
Personalis, Inc.

2022 Q4 Form 10-Q Financial Statement

#000095017022021272 Filed on November 02, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $16.72M $14.86M $22.26M
YoY Change -19.15% -33.26% 12.34%
Cost Of Revenue $14.41M $12.38M $14.20M
YoY Change 13.59% -12.79% -1.97%
Gross Profit $2.312M $2.479M $8.066M
YoY Change -71.09% -69.27% 51.33%
Gross Profit Margin 13.83% 16.68% 36.23%
Selling, General & Admin $17.83M $14.78M $12.14M
YoY Change 30.05% 21.75% 55.84%
% of Gross Profit 771.11% 596.25% 150.51%
Research & Development $16.57M $14.96M $13.62M
YoY Change 14.17% 9.84% 89.39%
% of Gross Profit 716.65% 603.35% 168.82%
Depreciation & Amortization $2.956M $1.900M $1.500M
YoY Change 84.63% 26.67% 0.0%
% of Gross Profit 127.85% 76.64% 18.6%
Operating Expenses $34.40M $29.74M $25.76M
YoY Change 21.88% 15.46% 71.83%
Operating Profit -$32.09M -$27.26M -$17.69M
YoY Change 58.64% 54.08% 83.14%
Interest Expense $1.113M $45.00K $28.00K
YoY Change 4959.09% 60.71% -76.67%
% of Operating Profit
Other Income/Expense, Net -$88.00K $80.00K $5.000K
YoY Change -8900.0% 1500.0%
Pretax Income -$31.06M -$26.48M -$17.66M
YoY Change 53.75% 49.97% 85.09%
Income Tax $8.000K $11.00K $12.00K
% Of Pretax Income
Net Earnings -$31.07M -$26.49M -$17.67M
YoY Change 53.81% 49.93% 85.12%
Net Earnings / Revenue -185.79% -178.3% -79.38%
Basic Earnings Per Share -$0.58 -$0.40
Diluted Earnings Per Share -$0.67 -$0.58 -$397.0K
COMMON SHARES
Basic Shares Outstanding 45.97M 45.92M 44.41M
Diluted Shares Outstanding 45.92M 44.51M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $167.7M $192.8M $305.2M
YoY Change -41.6% -36.85% 48.1%
Cash & Equivalents $89.13M $83.52M $79.57M
Short-Term Investments $78.53M $109.2M $225.7M
Other Short-Term Assets $6.808M $8.017M $7.728M
YoY Change -3.96% 3.74% -14.13%
Inventory $8.591M $7.543M $5.523M
Prepaid Expenses
Receivables $16.64M $13.59M $10.53M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $199.7M $221.9M $329.0M
YoY Change -37.25% -32.55% 47.14%
LONG-TERM ASSETS
Property, Plant & Equipment $61.94M $61.22M $72.61M
YoY Change 215.19% -15.69% 210.31%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.586M $4.689M $5.067M
YoY Change -4.95% -7.46% 166.68%
Total Long-Term Assets $93.00M $95.95M $77.68M
YoY Change 18.78% 23.53% 208.25%
TOTAL ASSETS
Total Short-Term Assets $199.7M $221.9M $329.0M
Total Long-Term Assets $93.00M $95.95M $77.68M
Total Assets $292.7M $317.9M $406.7M
YoY Change -26.18% -21.84% 63.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.85M $10.78M $7.288M
YoY Change 39.4% 47.97% 12.12%
Accrued Expenses $1.700M $5.522M $977.0K
YoY Change 92.53% 465.2% 184.84%
Deferred Revenue $1.264M $297.0K
YoY Change -68.26%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.218M $2.178M $1.775M
YoY Change 22.81% 22.7%
Total Short-Term Liabilities $33.13M $33.74M $26.52M
YoY Change 5.81% 27.24% -26.14%
LONG-TERM LIABILITIES
Long-Term Debt $378.0K $370.0K $1.660M
YoY Change -77.61% -77.71%
Other Long-Term Liabilities $389.0K $374.0K $53.22M
YoY Change -81.62% -99.3% 466.19%
Total Long-Term Liabilities $389.0K $374.0K $54.88M
YoY Change -81.62% -99.32% 483.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $33.13M $33.74M $26.52M
Total Long-Term Liabilities $389.0K $374.0K $54.88M
Total Liabilities $74.56M $75.46M $81.40M
YoY Change -13.53% -7.29% 79.69%
SHAREHOLDERS EQUITY
Retained Earnings -$360.4M -$329.3M
YoY Change 45.86%
Common Stock $579.5M $573.2M
YoY Change 3.93%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $218.1M $242.4M $325.3M
YoY Change
Total Liabilities & Shareholders Equity $292.7M $317.9M $406.7M
YoY Change -26.18% -21.84% 63.46%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$31.07M -$26.49M -$17.67M
YoY Change 53.81% 49.93% 85.12%
Depreciation, Depletion And Amortization $2.956M $1.900M $1.500M
YoY Change 84.63% 26.67% 0.0%
Cash From Operating Activities -$16.76M -$14.76M -$17.88M
YoY Change 9.74% -17.42% 10.92%
INVESTING ACTIVITIES
Capital Expenditures $9.538M -$21.41M -$2.962M
YoY Change -366.65% 622.96% 91.1%
Acquisitions
YoY Change
Other Investing Activities $31.39M $32.24M $32.63M
YoY Change -27.82% -1.2% 352.58%
Cash From Investing Activities $21.85M $10.83M $29.67M
YoY Change -45.25% -63.51% 425.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 511.0K 760.0K -506.0K
YoY Change -62.06% -250.2% -100.43%
NET CHANGE
Cash From Operating Activities -16.76M -14.76M -17.88M
Cash From Investing Activities 21.85M 10.83M 29.67M
Cash From Financing Activities 511.0K 760.0K -506.0K
Net Change In Cash 5.600M -3.179M 11.28M
YoY Change -78.45% -128.18% -89.57%
FREE CASH FLOW
Cash From Operating Activities -$16.76M -$14.76M -$17.88M
Capital Expenditures $9.538M -$21.41M -$2.962M
Free Cash Flow -$26.30M $6.649M -$14.92M
YoY Change 124.84% -144.57% 2.39%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001527753
dei Amendment Flag
AmendmentFlag
false
CY2021Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#AccountsPayableCurrent
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2022Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#AccountsPayableCurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38943
dei Entity Registrant Name
EntityRegistrantName
Personalis, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-5411038
dei Entity Address Address Line1
EntityAddressAddressLine1
1330 O’Brien Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Menlo Park
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94025
dei City Area Code
CityAreaCode
650
dei Local Phone Number
LocalPhoneNumber
752-1300
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001
dei Trading Symbol
TradingSymbol
PSNL
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
us-gaap Investment Income Interest
InvestmentIncomeInterest
286000
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
45971355
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
83522000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
105585000
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
109234000
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
181479000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13592000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
18468000
CY2022Q3 psnl Inventory And Other Deferred Costs
InventoryAndOtherDeferredCosts
7543000
CY2021Q4 psnl Inventory And Other Deferred Costs
InventoryAndOtherDeferredCosts
5610000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8017000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7089000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
221908000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
318231000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
61219000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19650000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
30045000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
53822000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4689000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4825000
CY2022Q3 us-gaap Assets
Assets
317861000
CY2021Q4 us-gaap Assets
Assets
396528000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
10784000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
9221000
CY2022Q3 psnl Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
22658000
CY2021Q4 psnl Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
18110000
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
297000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3982000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
33739000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
31313000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
41349000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
52797000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
374000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2117000
CY2022Q3 us-gaap Liabilities
Liabilities
75462000
CY2021Q4 us-gaap Liabilities
Liabilities
86227000
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45955866
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45955866
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44904512
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44904512
CY2022Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
5000
CY2021Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
4000
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
573158000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
557558000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1422000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-166000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-329342000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-247095000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
242399000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
310301000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
317861000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
396528000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14858000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22261000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
48325000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
64812000
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
12379000
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
14195000
us-gaap Cost Of Revenue
CostOfRevenue
37287000
us-gaap Cost Of Revenue
CostOfRevenue
41151000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14957000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13617000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
48343000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
34800000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
14781000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12140000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
46141000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
33989000
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
42117000
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
39952000
us-gaap Costs And Expenses
CostsAndExpenses
131771000
us-gaap Costs And Expenses
CostsAndExpenses
109940000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-27259000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-17691000
us-gaap Operating Income Loss
OperatingIncomeLoss
-83446000
us-gaap Operating Income Loss
OperatingIncomeLoss
-45128000
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
743000
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
88000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1236000
CY2022Q3 us-gaap Interest Expense
InterestExpense
45000
CY2021Q3 us-gaap Interest Expense
InterestExpense
60000
us-gaap Interest Expense
InterestExpense
154000
us-gaap Interest Expense
InterestExpense
125000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
80000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
149000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-43000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-26481000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17658000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-82215000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-45010000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-26492000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-17670000
us-gaap Net Income Loss
NetIncomeLoss
-82247000
us-gaap Net Income Loss
NetIncomeLoss
-45027000
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.58
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.58
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.40
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.40
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.81
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.81
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.03
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45921411
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45921411
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44511534
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44511534
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45518334
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45518334
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43579308
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43579308
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-26492000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-17670000
us-gaap Net Income Loss
NetIncomeLoss
-82247000
us-gaap Net Income Loss
NetIncomeLoss
-45027000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-215000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-9000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-417000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
12000
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
57000
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-839000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-22000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26650000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17676000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-83503000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-45037000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
264632000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4415000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-215000
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
57000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-26492000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
242399000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
338747000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
536000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3689000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-9000
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-17670000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
325296000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
310301000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
981000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
974000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13646000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-417000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-839000
us-gaap Net Income Loss
NetIncomeLoss
-82247000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
242399000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
194945000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
161916000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1935000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1191000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10346000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
12000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-22000
us-gaap Net Income Loss
NetIncomeLoss
-45027000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
325296000
us-gaap Profit Loss
ProfitLoss
-82247000
us-gaap Profit Loss
ProfitLoss
-45027000
us-gaap Share Based Compensation
ShareBasedCompensation
13646000
us-gaap Share Based Compensation
ShareBasedCompensation
10346000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5476000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4413000
psnl Noncash Lease Expense
NoncashLeaseExpense
3612000
psnl Noncash Lease Expense
NoncashLeaseExpense
1732000
psnl Amortization Of Premium Discount On Short Term Investments
AmortizationOfPremiumDiscountOnShortTermInvestments
-365000
psnl Amortization Of Premium Discount On Short Term Investments
AmortizationOfPremiumDiscountOnShortTermInvestments
-1554000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
23000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-111000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4876000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4184000
psnl Increase Decrease In Inventories And Other Deferred Costs
IncreaseDecreaseInInventoriesAndOtherDeferredCosts
1935000
psnl Increase Decrease In Inventories And Other Deferred Costs
IncreaseDecreaseInInventoriesAndOtherDeferredCosts
-117000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
357000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3542000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1073000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3530000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1632000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1839000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-3685000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-18067000
psnl Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
9928000
psnl Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-952000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-422000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-364000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-53471000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-55554000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
111179000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
227316000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
182223000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
129783000
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
5059000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
40358000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7506000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
30686000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-99980000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
162258000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
342000
psnl Proceeds From Payment Agreements With Financing Entity
ProceedsFromPaymentAgreementsWithFinancingEntity
1194000
psnl Proceeds From Payment Agreements With Financing Entity
ProceedsFromPaymentAgreementsWithFinancingEntity
5167000
psnl Repayments Of Payment Agreements With Financing Entity
RepaymentsOfPaymentAgreementsWithFinancingEntity
2293000
psnl Repayments Of Payment Agreements With Financing Entity
RepaymentsOfPaymentAgreementsWithFinancingEntity
1857000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1954000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3127000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
855000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
168353000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-133000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
18000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-22063000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12837000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
107375000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
68525000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
85312000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
81362000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
83522000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
79572000
CY2022Q3 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
1790000
CY2021Q3 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
1790000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
85312000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
81362000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Arial&quot;, sans-serif;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:6.667%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities, at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The estimates include, but are not limited to, useful lives assigned to long-lived assets, discount rates for lease accounting, the valuation of stock options, the valuation of stock-based awards, and provisions for income taxes and contingencies. Actual results could differ from these estimates, and such differences could be material to the Company’s consolidated financial position and results of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;"> </span></p>
CY2022Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5864000
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
4081000
CY2022Q3 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
1679000
CY2021Q4 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
1529000
CY2022Q3 psnl Inventory And Other Deferred Costs
InventoryAndOtherDeferredCosts
7543000
CY2021Q4 psnl Inventory And Other Deferred Costs
InventoryAndOtherDeferredCosts
5610000
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1900000
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
100000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
100000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0
us-gaap Dividends Common Stock
DividendsCommonStock
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1500000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5500000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4400000
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
24300000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4934000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3728000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5522000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
883000
CY2022Q3 us-gaap Loans Payable Current
LoansPayableCurrent
2178000
CY2021Q4 us-gaap Loans Payable Current
LoansPayableCurrent
1806000
CY2022Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
561000
CY2021Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
517000
CY2022Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
526000
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
121000
CY2022Q3 psnl Contract With Customer Deposits Current
ContractWithCustomerDepositsCurrent
30000
CY2021Q4 psnl Contract With Customer Deposits Current
ContractWithCustomerDepositsCurrent
382000
CY2022Q3 psnl Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
22658000
CY2021Q4 psnl Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
18110000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14858000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22261000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
48325000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
64812000
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
300000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
4000000.0
CY2022Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
200000
CY2021Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
9700000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3700000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
19100000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19000000.0
CY2022Q3 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
1800000
CY2021Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
1800000
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8907000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10673000
CY2022Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
0
CY2015Q4 us-gaap Land Subject To Ground Leases
LandSubjectToGroundLeases
31280
CY2020 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2027-11-30
us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
an option to extend the term for a period of three years
CY2020 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2020Q4 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P3Y
CY2021Q4 us-gaap Land Subject To Ground Leases
LandSubjectToGroundLeases
14710
CY2021 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2022-12-31
CY2021 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
no option to extend the term
CY2021 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
false
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
2121000
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1423000
us-gaap Operating Lease Cost
OperatingLeaseCost
6469000
us-gaap Operating Lease Cost
OperatingLeaseCost
2844000
CY2022Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
10000
CY2021Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
72000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
47000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
334000
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
357000
CY2021Q3 us-gaap Variable Lease Cost
VariableLeaseCost
369000
us-gaap Variable Lease Cost
VariableLeaseCost
1003000
us-gaap Variable Lease Cost
VariableLeaseCost
763000
CY2022Q3 us-gaap Lease Cost
LeaseCost
2488000
CY2021Q3 us-gaap Lease Cost
LeaseCost
1864000
us-gaap Lease Cost
LeaseCost
7519000
us-gaap Lease Cost
LeaseCost
3941000
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P11Y2M12D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.105
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1078000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
5710000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
7895000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
7808000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
7168000
CY2022Q3 psnl Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
55202000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
84861000
CY2022Q3 psnl Lessee Operating Lease Liability Discount On Obligation Amount
LesseeOperatingLeaseLiabilityDiscountOnObligationAmount
38578000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
46283000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4934000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
41349000
us-gaap Operating Lease Payments
OperatingLeasePayments
3300000
us-gaap Operating Lease Payments
OperatingLeasePayments
2300000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3100000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
46400000
CY2022Q3 psnl Shares Subject To Options And Restricted Stock Or Rsu Awards
SharesSubjectToOptionsAndRestrictedStockOrRSUAwards
8737479
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2254563
CY2022Q3 psnl Shares Of Common Stock Reserved For Future Issuance Under Espp
SharesOfCommonStockReservedForFutureIssuanceUnderESPP
827618
CY2022Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
11819660
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.50
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
12.53
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.60
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
13.32
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
14800000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y4M24D
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6529381
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.7179
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.7635
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.6881
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.6931
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.6837
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.7635
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.6806
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.6990
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0284
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0363
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0086
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0096
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0162
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0363
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0062
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0106
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4415000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3689000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13646000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10346000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4415000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3689000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13646000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10346000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-26492000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-17670000
us-gaap Net Income Loss
NetIncomeLoss
-82247000
us-gaap Net Income Loss
NetIncomeLoss
-45027000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45921411
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45921411
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44511534
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44511534
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45518334
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45518334
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43579308
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43579308
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.58
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.58
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.40
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.40
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.81
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.81
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.03
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8854911
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6529381
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8854911

Files In Submission

Name View Source Status
0000950170-22-021272-index-headers.html Edgar Link pending
0000950170-22-021272-index.html Edgar Link pending
0000950170-22-021272.txt Edgar Link pending
0000950170-22-021272-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img21612419_0.jpg Edgar Link pending
img79143280_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
psnl-20220930.htm Edgar Link pending
psnl-20220930.xsd Edgar Link pending
psnl-ex10_1.htm Edgar Link pending
psnl-ex31_1.htm Edgar Link pending
psnl-ex31_2.htm Edgar Link pending
psnl-ex32_1.htm Edgar Link pending
psnl-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
psnl-20220930_lab.xml Edgar Link unprocessable
psnl-20220930_pre.xml Edgar Link unprocessable
psnl-20220930_cal.xml Edgar Link unprocessable
psnl-20220930_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
psnl-20220930_def.xml Edgar Link unprocessable